TY - JOUR AN - 06 AU - Pfreundschuh,M. TI - German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL), Medizinische Klinik I, Saarland University Medical School, Homburg, Saarland, Germany. Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) JO - Blood PY - 2005 VL - 106 (11) ER -